Close

Sign in
Sign up

Menu

Data Search
Content
Startup Concierge
Newsletters
Get intel

Home
News
NRG Therapeutics closed a £50 million Series B funding round w/ British Business Bank, SV Health, M Ventures, Novartis, Criteria Bio Ventures, Omega Funds

NRG Therapeutics closed a £50 million Series B funding round w/ British Business Bank, SV Health, M Ventures, Novartis, Criteria Bio Ventures, Omega Funds

Biotech Health services Pharma

Spain

Switzerland

United Kingdom

Netherlands

United States

Australia

Investments

01 September 2025

Share:

Interested in more dealflow and deeper data sets from Europe? Please consider joining Nordic 9!

NRG Therapeutics (company)

United Kingdom

Biotech Health services Pharma

Total investments received (USD): 85.97M

Round value (USD): 67.25M

Round investors: SV Health Investors Merck Ventures Novartis Venture Fund Caixa Capital Risc Brandon Capital Partners Omega Funds British Business Bank

Company: NRG Therapeutics

Industry: Biotech Health services Pharma

Related deals

Tenpoint Therapeutics raises $85M series B with Janus Henderson Investors, Hillhouse Investment, EQT and British Business Bank

Biotech Health services

Sweden

Switzerland

France

United Kingdom

United States

China

Investments 30 January 2026

Beacon Tx raised $75m in Series C led by Goldman Sachs Alternatives, joined by the RD Fund, Syncona, Forbion, Oxford Science Enterprises, and Advent.

Health services Manufacturing Pharma

United Kingdom

Netherlands

United States

Investments 29 December 2025

Bit.bio raised $50m in Series C funding round led by M&G Investments.

Biotech Competitive Intelligence Health services Software Services

Germany

United Kingdom

United States

China

Investments 29 December 2025

Elevara Medicines raised $70m in Series A funding led by Forbion and Sofinnova Partners, joined by insiders Monograph Capital and Weatherden.

Health services Pharma

France

United Kingdom

Netherlands

Investments 02 October 2025

Trogenix raised €80m in Series A led by IQ Capital, joined by 4Bio, Cancer Research Horizons, Brain Tumour Fund, Eli Lilly, Meltwind, LongeVC and Calculus

Biotech Health services Manufacturing Pharma Software Services

United Kingdom

United States

Latvia

Investments 01 October 2025

Sidebar

Verticals

Financial Services
Food Industry
Education
E-commerce
Health services
Marketplace

Benelux

Belgium
Netherlands

DACH

Austria
Germany
Switzerland

Nordics and Baltics

Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden

Western Europe

France
Ireland
Italy
Portugal
Spain
United Kingdom

About
Contact
Terms of service
Privacy policy

© All rights reserved Nordic 9 2016-2026. Made with in Stockholm

Top